Author: NanoMosaic, Inc.

Posted Date:

April 29, 2026

NanoMosaic to Showcase the FDA/CBER AMT Designated Analytics Platform at ASGCT 2026

NanoMosaic, Inc.

April 29, 2026
NanoMosaic Secures FDA Advanced Manufacturing Technology (AMT) Designation for Advanced Gene Therapy Analytics

NanoMosaic, Inc.

January 29, 2026